Find Clinical Trial


Trial Status:
Gender:
Condition:

CLINICAL TRIALS

Previous Page        Next Page

Free trial of light therapy for hair loss Are you male? Have premature hair loss that is troubling you? Are you 18 to 60 years old? You are likely eligible…

CONDITION: Skin

TRIAL STATUS: Recruiting

GENDER: Males

AGE GROUP: 18 years to 60 years

What is the trial? Sponsor is developing the product RYI-018 as a potential treatment for non-alcoholic fatty liver disease (NAFLD), which is a very common disorder and refers to a…

CONDITION:

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 years to 65 years

Adults and Children ages 9+ may qualify for a study of an investigational facial acne medication. To participate you must: Have at least 20 red irritated pimples and at least…

CONDITION: Skin

TRIAL STATUS: Completed

GENDER: Both males and females

AGE GROUP: 9 years and above

Help us trial a medication which may help to protect people against severe reactions to peanuts. We’re looking for healthy people aged 18-65 with with a documented peanut allergy (of…

CONDITION: Other

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 years to 65 years

Currently the known risk of a woman being diagnosed with cervical cancer by the age of 85 years is 1 in 160. The study we are conducting will be investigating a…

CONDITION: Other

TRIAL STATUS: Recruiting

GENDER: Females

AGE GROUP: 18 years to 50 years

Australian researchers are trialing a potential new treatment for Asthma. They are looking for volunteers to take part in the Australian arm of a worldwide study. This study will be…

CONDITION: Respiratory

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 years to 100 years

ANB019-001: This study is investigating the drug ANB019 to treat Plaque Psoriasis and other related conditions also associated with abnormal inflammatory responses. ANB019 is a monoclonal antibody (mAb) meaning that it…

CONDITION: Inflammatory and Immune System

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 years to 45 years

Are you aged between 50 and 80? Do you have Diabetes? You could play a role in the prevention of heart disease by participating in the ViKCoVaC study. Led by…

CONDITION: Cardiovascular

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 50 years to 80 years

This is a phase 2, open-label trial designed to evaluate the safety, tolerability, biologic activity, and preliminary efficacy of intratumoral SD 101 injections in combination with Keytruda (pembrolizumab) in patients…

CONDITION: Cancer

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 years and above

Linear is currently inviting volunteers who have impaired function of their pancreas (a condition called exocrine pancreatic insufficiency, or EPI).  This condition is often caused by chronic pancreatitis, or where part…

CONDITION: Metabolic and Endocrine

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 years and above

The study is conducted in response to the need to maintain older adults’ daily functioning through stimulating environments despite the aging process. This study will involve older adults playing video games…

CONDITION: Other

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 40 years and above

The purpose of this study is to collect data. The sponsor will be collecting medical information from study participants (through an interview and a phone call up to 7 days…

CONDITION: Blood

TRIAL STATUS: Terminated

GENDER: Both males and females

AGE GROUP: 18 years and above

20150164: This study is investigating a drug that has been developed for the treatment of a disease called Paroxysmal nocturnal hemoglobinuria (PNH) – PNH is a disease where red blood…

CONDITION: Other

TRIAL STATUS: Completed

GENDER: Males

AGE GROUP: 18 years to 45 years

This is a Phase 2 study for osteoarthritis of the knee pain looking at Cannabidiol (CBD), which is part of the Cannabis/Marijuana plant but does not have the effects on the…

CONDITION: Musculoskeletal

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 40 years and above

This is a phase 3 multicenter, randomised, placebo-controlled, double-blind study to evaluate efficacy and safety of Certolizumab Pegol in participants with active axial spondyloarthritis (axSpA) without x-ray evidence of ankylosing…

CONDITION: Musculoskeletal

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 years and above

Are you in Good Health? Are you aged 18 or over? Do you live in Sydney? You may qualify* to take part in a trial looking at the potential changes…

CONDITION: Oral and Gastrointestinal

TRIAL STATUS: Closed: follow-up continuing

GENDER: Both males and females

AGE GROUP: 18 years and above

What is COMPARE? COMPARE is an Australian national randomised controlled trial which aims to compare two types of intensive speech pathology treatments (Constraint Induced Aphasia Therapy; Multi-modality Aphasia Therapy) to…

CONDITION: Stroke

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 years

CONDITION: Neurological

TRIAL STATUS: Recruiting

GENDER: Both males and females

AGE GROUP: 18 years and above

This is a phase I study assessing the safety and tolerability of single dose of a study drug which is being developed for the treatment of hyperuricemia and gout. Eligible…

CONDITION: Other

TRIAL STATUS: Closed: follow-up complete

GENDER: Males

AGE GROUP: 18 years to 50 years

This is an open label, phase I study assessing the safety and tolerability of a pharmaceutical formulation comprising a protein that is being developed as a treatment for acute ischemic stroke.…

CONDITION:

TRIAL STATUS: Closed: follow-up continuing

GENDER: Both males and females

AGE GROUP: 18 years to 50 years


Previous Page        Next Page